The latest closing stock price for BioXcel Therapeutics as of May 14, 2025 is 1.37.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-992 today, roughly -1 times their original investment - a -50.05% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 1034.08 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 35.04, which is 2457.7% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 1.29, which is 5.8% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 9.65.
An investor who bought $1,000 worth of BioXcel Therapeutics stock at the IPO in 2018 would have $-992 today, roughly -1 times their original investment - a -50.05% compound annual growth rate over 7 years.
The all-time high BioXcel Therapeutics stock closing price was 1034.08 on July 22, 2020.
The BioXcel Therapeutics 52-week high stock price is 35.04, which is 2457.7% above the current share price.
The BioXcel Therapeutics 52-week low stock price is 1.29, which is 5.8% below the current share price.
The average BioXcel Therapeutics stock price for the last 52 weeks is 9.65.